This free Collaborative Online International Learning (COIL) course provides a clear and accessible overview of how medicines progress from early discovery through pre-clinical testing, clinical trials, regulatory approval, and post-marketing surveillance. Developed jointly by academics from King’s and industry experts, the course is designed for students from pharmacy, life sciences, biomedical sciences, medicine, clinical research, and allied health disciplines.
The activity spans from 9th March 2026 to 10th April 2026
The course is structured around recorded lectures, interactive workshops, group discussions, and formative and summative quizzes. Students will explore drug discovery challenges, manufacturing and quality requirements for clinical trials, toxicology and pharmacogenomics, regulatory submissions such as INDs, and the design and conduct of clinical trials.
The course sits alongside a complementary COIL course in Development and Regulation of Generic Drugs, offered by BRAC University in Bangladesh. Students are encouraged to participate in both courses, but this is not mandatory. For more details on the COIL offered by BRAC, please click here:
https://edge.kcl.ac.uk/events/coil-course-development-and-regulation-of-generic-drugs
There will be an interactive workshop on Tuesday 7th April using real-world scenarios to reinforce and apply the key learning outcomes of the COIL course, in which students from BRAC University in Bangladesh will also participate, providing the opportunity to meet with and learn from students in a global classroom context.
This course is ideal for students who want to understand how scientific discoveries translate into safe and effective medicines, and how regulators, clinicians, and industry work together across the drug development lifecycle.
Event ID: 01483-D7L8N